Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease.
Marina PicilloOnanong PhokaewvarangkulYu-Yan PoonCameron C McIntyreSinem Balta BeylergilRenato P MunhozSuneil K KaliaMojgan HodaieAndres M LozanoAlfonso FasanoPublished in: Movement disorders : official journal of the Movement Disorder Society (2020)
This trial provides evidence for simplifying pharmacological treatment after functional neurosurgery for PD. The reduction in dopamine receptor agonists should be attempted while monitoring for occurrence of NMSs, such as apathy and sleep disturbances. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.